Cargando…
Blocking TCR restimulation induced necroptosis in adoptively transferred T cells improves tumor control
Advancements in adoptive cell transfer therapy (ACT) has led to the use of T cells engineered with tumor specific T cell receptors, which after rapid expansion can be obtained in sufficient numbers for treating patients. However, due to massive proliferation these cells are close to replicative sene...
Autores principales: | Kesarwani, Pravin, Chakraborty, Paramita, Gudi, Radhika, Chatterjee, Shilpak, Scurti, Gina, Toth, Kyle, Simms, Patt, Husain, Mahvash, Armeson, Kent, Husain, Shahid, Garrett-Mayer, Elizabeth, Vasu, Chethamarakshan, Nishimura, Michael I., Mehrotra, Shikhar |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5342484/ https://www.ncbi.nlm.nih.gov/pubmed/27750220 http://dx.doi.org/10.18632/oncotarget.12674 |
Ejemplares similares
-
Interferon-Gamma (IFN-γ)-Mediated Retinal Ganglion Cell Death in Human Tyrosinase T Cell Receptor Transgenic Mouse
por: Husain, Shahid, et al.
Publicado: (2014) -
CD38-NAD(+)-Sirt1 axis in T cell immunotherapy
por: Chatterjee, Shilpak, et al.
Publicado: (2019) -
Dynamic Metabolism in Immune Response
por: Al-Hommrani, Mazen, et al.
Publicado: (2016) -
CD38: T Cell Immuno-Metabolic Modulator
por: Kar, Anwesha, et al.
Publicado: (2020) -
The role of the adaptive immune system and T cell dysfunction in neurodegenerative diseases
por: DeMaio, Alexa, et al.
Publicado: (2022)